SIA
WST icon

SkyView Investment Advisors’s West Pharmaceutical WST Stock Holding History

SkyView Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$2K – 765
2023
Q2 		$2K Buy
5
+3
+150% +$1.07K ﹤0.01% 602
2023
Q1 		$1K Buy
+2
New +$584 ﹤0.01% 635

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

SkyView Investment Advisors's WST Position: Q3 2023 in Review

SkyView Investment Advisors sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 5 shares — an estimated $2K sold.

SkyView Investment Advisors first reported a position in WST in Q1 2023 and held it in 2 quarters. The position peaked at $2K in Q2 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • SkyView Investment Advisors reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 5 West Pharmaceutical shares in Q3 2023, an estimated $2K.
  • SkyView Investment Advisors first reported a position in West Pharmaceutical in Q1 2023 and held it in 2 quarters.
  • SkyView Investment Advisors's West Pharmaceutical position peaked at $2K in Q2 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on SkyView Investment Advisors's 13F filing for Q3 2023, filed 17 Nov 2023.